212
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Plasma levels of guanylins are reduced in patients with Crohn’s disease

ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 449-453 | Received 27 Feb 2020, Accepted 21 Mar 2020, Published online: 20 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Adi Caspi, Ariana A Entezari, Madison Crutcher, Adam E Snook & Scott A Waldman. (2022) Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer. Personalized Medicine 19:5, pages 457-472.
Read now

Articles from other publishers (4)

Aleksandra Kałużna, Agnieszka Jura-Półtorak, Alicja Derkacz, Krystyna Olczyk & Katarzyna Komosinska-Vassev. (2023) Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease. Biomolecules 13:10, pages 1448.
Crossref
Ingeborg Brønstad, Hilde Løland von Volkmann, Sunniva Todnem Sakkestad, Hans Steinsland & Kurt Hanevik. (2023) Reduced Plasma Guanylin Levels Following Enterotoxigenic Escherichia coli-Induced Diarrhea. Microorganisms 11:8, pages 1997.
Crossref
Hari Prasad, John Kandam Kulathu Mathew & Sandhya S. Visweswariah. (2022) Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities. Frontiers in Endocrinology 13.
Crossref
Yunki Y Yau, Valerie C Wasinger, Robert P Hirten, Emil Chuang, Merodean Huntsman, Jack Stylli, Jeff Shimizu, Vijay Yajnik, Jeffrey Smith, Shaoying N Lee, Sharat Singh, Christopher Wahl, Rupert W Leong & Bruce E Sands. (2021) Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System. Inflammatory Bowel Diseases 27:Supplement_2, pages S17-S24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.